Reactions Catalyzed by the Heme Domain of Inducible Nitric Oxide Synthase:
Evidence for the Involvement of Tetrahydrobiopterin in Electron Transfer
†
Amy R. Hurshman
‡
and Michael A. Marletta*
,‡,§,|
Howard Hughes Medical Institute, Department of Medicinal Chemistry, and Department of Biological Chemistry,
UniVersity of Michigan, Ann Arbor, Michigan 48109-0606
ReceiVed NoVember 1, 2001
ABSTRACT: The heme domain (iNOS
heme
) of inducible nitric oxide synthase (iNOS) was expressed in
Escherichia coli and purified to homogeneity. Characterization of the expressed iNOS
heme
shows it to
behave in all respects like full-length iNOS. iNOS
heme
is isolated without bound pterin but can be readily
reconstituted with (6R)-5,6,7,8-tetrahydro-L-biopterin (H
4
B) or other pterins. The reactivity of pterin-
bound and pterin-free iNOS
heme
was examined, using sodium dithionite as the reductant. H
4
B-bound
iNOS
heme
catalyzes both steps of the NOS reaction, hydroxylating arginine to N
G
-hydroxy-L-arginine (NHA)
and oxidizing NHA to citrulline and •NO. Maximal product formation (0.93 ( 0.12 equiv of NHA from
arginine and 0.83 ( 0.08 equiv of citrulline from NHA) requires the addition of 2 to 2.5 electron equiv.
Full reduction of H
4
B-bound iNOS
heme
with dithionite also requires 2 to 2.5 electron equiv. These data
together demonstrate that fully reduced H
4
B-bound iNOS
heme
is able to catalyze the formation of 1 equiv
of product in the absence of electrons from dithionite. Arginine hydroxylation requires the presence of a
bound, redox-active tetrahydropterin; pterin-free iNOS
heme
or iNOS
heme
reconstituted with a redox-inactive
analogue, 6(R,S)-methyl-5-deaza-5,6,7,8-tetrahydropterin, did not form NHA under these conditions. H
4
B
has an integral role in NHA oxidation as well. Pterin-free iNOS
heme
oxidizes NHA to citrulline, N
δ
-
cyanoornithine, an unidentified amino acid, and NO
-
. Maximal product formation (0.75 ( 0.01 equiv of
amino acid products) requires the addition of 2 to 2.5 electron equiv, but reduction of pterin-free iNOS
heme
requires only 1 to 1.5 electron equiv, indicating that both electrons for the oxidation of NHA by pterin-
free iNOS
heme
are derived from dithionite. These data provide strong evidence that H
4
B is involved in
electron transfer in NOS catalysis.
The biosynthesis of •NO is catalyzed by the enzyme nitric
oxide synthase (NOS,
1
EC 1.14.13.39) in a reaction that also
forms citrulline from the amino acid L-arginine (for reviews,
see refs 1-3). In this five-electron oxidation, •NO is derived
from one of the terminal guanidino nitrogens of arginine.
The reaction proceeds in two steps, both of which require
NADPH and O
2
as cosubstrates. The first step of the reaction
is the hydroxylation of arginine, forming N
G
-hydroxy-L-
arginine (NHA) as an intermediate (4-6). NHA is further
oxidized by three electrons in the second step to form
citrulline and •NO. Three isoforms of NOS have been
characterized: a particulate, constitutive enzyme from vas-
cular endothelium (eNOS), a soluble, constitutive enzyme
from neuronal cells (nNOS), and an inducible enzyme, best
characterized from murine macrophages (iNOS) (7). All of
the isoforms are homodimeric and bind an equivalent each
of FAD, FMN (8-10), and protoporphyrin IX heme (11-
13) per subunit. Full activity also requires one bound H
4
B
per monomer (10, 14, 15).
The roles of the enzyme-bound heme and H
4
B in the
reaction mechanism are not fully understood. CO inhibition
studies have suggested a catalytic role for the heme in both
steps of the NOS reaction (16, 11). Further evidence for the
involvement of the heme in NHA oxidation comes from NOS
reactions where hydrogen peroxide is substituted for NADPH
and O
2
(peroxide-shunt reactions). The products of the
peroxide-shunt reactions are consistent with a heme ferric-
peroxide nucleophile as an intermediate in the NADPH-
dependent oxidation of NHA (17, 18). A model for the
enzymatic oxidation of NHA to citrulline and •NO, using
an Fe
III
porphyrin and O
2
, has also been reported (19). The
role of the heme in the hydroxylation of arginine has been
less clear. Crystal structures of several NOS heme domains
†
This research was supported by Howard Hughes Medical Institute
and NIH Grant CA 50414. A.R.H. was supported by NIH Grant T32-
GM07767, a Regents’ Fellowship from the University of Michigan,
and an American Foundation for Pharmaceutical Education Fellowship.
* To whom correspondence should be addressed at University of
California, Berkeley, Department of Chemistry, 211 Lewis Hall,
Berkeley, CA 94720-1460. Phone: (510) 643-9325; Fax: (510) 643-
9388; E-mail: marletta@cchem.berkeley.edu.
‡
Department of Medicinal Chemistry, University of Michigan.
§
Howard Hughes Medical Institute, University of Michigan.
|
Department of Biological Chemistry, University of Michigan.
1
Abbreviations: NOS, nitric oxide synthase; eNOS, endothelial
NOS; nNOS, neuronal NOS; iNOS, inducible NOS; iNOSheme, heme
domain of inducible NOS; NHA, N
G
-hydroxy-L-arginine; H4B, (6R)-
5,6,7,8-tetrahydro-L-biopterin; 7,8-H2B, (6R)-7,8-dihydro-L-biopterin;
MPH4, 6(R,S)-methyl-5,6,7,8-tetrahydropterin; DZPH4, 6(R,S)-methyl-
5-deaza-5,6,7,8-tetrahydropterin; DTT, dithiothreitol; CN-orn, N
δ
-
cyanoornithine; HEPES, 4-(2-hydroxyethyl)-1-piperazineethane sulfonic
acid; Tris-HCl, Tris[hydroxymethyl]aminomethane hydrochloride; IPTG,
isopropyl--D-thiogalactopyranoside; PVDF, polyvinylidine fluoride;
PCA, protocatechuic acid; PCD, protocatechuate 3,4-dioxygenase; Ni-
NTA, nickel-nitrilotriacetic acid agarose; BSA, bovine serum albumin;
NDA, 2,3-naphthalene dicarboxaldehyde; EDTA, ethylenediamine-
N,N,N′,N′-tetraacetic acid; TFA, trifluoroacetic acid; EPR, electron
paramagnetic resonance spectroscopy; PCR, polymerase chain reaction;
MALDI, matrix-assisted laser desorption/ionization; HPLC, high-
performance liquid chromatography; SDS-PAGE, sodium dodecyl
sulfate-polyacrylamide gel electrophoresis; ICP/MS, inductively coupled
plasma/mass spectrometry.
3439 Biochemistry 2002, 41, 3439-3456
10.1021/bi012002h CCC: $22.00 © 2002 American Chemical Society
Published on Web 02/12/2002